Gene: ECPAS
Official Full Name: Ecm29 proteasome adaptor and scaffoldprovided by HGNC
Gene Summary: Enables proteasome binding activity. Involved in ERAD pathway. Located in several cellular components, including centrosome; cytoplasmic vesicle; and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO29333 | ECPAS Knockout cell line (HeLa) | Human | ECPAS | 1:3~1:6 | Negative | Online Inquiry |
KO29334 | ECPAS Knockout cell line (HCT 116) | Human | ECPAS | 1:2~1:4 | Negative | Online Inquiry |
KO29335 | ECPAS Knockout cell line (HEK293) | Human | ECPAS | 1:3~1:6 | Negative | Online Inquiry |
KO29336 | ECPAS Knockout cell line (A549) | Human | ECPAS | 1:3~1:4 | Negative | Online Inquiry |
ECPAS Gene Knockout Cell Lines are sophisticated, genetically engineered models designed for the precise study of gene function and the biological pathways they influence. Developed through state-of-the-art gene-editing technologies such as CRISPR/Cas9, these models facilitate the targeted disruption of genes of interest, yielding insights into gene expression and its resultant phenotypic changes. By creating specific knockout mutations, researchers can elucidate the roles of genes in various biological processes, enabling a deeper understanding of cellular mechanisms underlying development, disease progression, and therapeutic responses.
The key function of ECPAS Gene Knockout Cell Lines lies in their ability to provide a robust platform for functional genomics. Each cell line is meticulously curated to exhibit a controlled disruption of specific genes, allowing scientists to analyze the resulting alterations in cellular behavior, protein interactions, and metabolic pathways. This mechanistic insight is invaluable not only in basic research but also in drug discovery and toxicity assessments.
Scientifically, these cell lines hold significant importance in both research and clinical applications. They can be employed in a multitude of studies, ranging from cancer research to understanding genetic disorders, thereby accelerating the identification of new therapeutic targets and running crucial preclinical drug evaluations.
ECPAS Gene Knockout Cell Lines stand out from alternative models by offering unparalleled specificity and reliability. Unlike traditional methods, which often produce inconclusive or varied results due to spontaneous mutations, ECPAS cell lines come with verified genetic integrity and consistency. Moreover, they offer easy integration into existing workflows, significantly reducing the time and resources typically spent on establishing knockout models from scratch.
For researchers, clinicians, and pharmaceutical companies, investing in ECPAS Gene Knockout Cell Lines translates into better experimental outcomes and faster advancements in scientific knowledge. The potential for high-quality, reproducible results ensures that these models are a top choice for anyone aiming to drive innovation in genetics and molecular biology.
Our company prides itself on its deep expertise in genetic engineering and commitment to supporting scientific discovery. With a wide range of biological products, we are dedicated to providing researchers with the tools necessary to pave the way for groundbreaking advancements in biomedical science.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.